| scholarly article | Q13442814 |
| P50 | author | Mark J. Olsen | Q73035272 |
| P2093 | author name string | Xiaoqun Dong | |
| Qi Tang | |||
| Jack R Wands | |||
| Qiushi Lin | |||
| Arihiro Aihara | |||
| Chiung-Kuei Huang | |||
| Waihong Chung | |||
| P2860 | cites work | Cloning and increased expression of an insulin receptor substrate - 1-like gene in human hepatocellular carcinoma | Q24328787 |
| Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma | Q24562001 | ||
| Sorafenib in advanced hepatocellular carcinoma | Q27861075 | ||
| Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is associated with malignant transformation | Q28139424 | ||
| Antisense oligodeoxynucleotides directed against aspartyl (asparaginyl) β-hydroxylase suppress migration of cholangiocarcinoma cells | Q28201030 | ||
| Role of the aspartyl-asparaginyl-beta-hydroxylase gene in neuroblastoma cell motility | Q28214662 | ||
| Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver | Q28246572 | ||
| Partial purification and characterization of bovine liver aspartyl beta-hydroxylase | Q28246732 | ||
| Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness | Q28303764 | ||
| The canonical Notch signaling pathway: unfolding the activation mechanism | Q29547725 | ||
| Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial | Q29547903 | ||
| Notch signalling: a simple pathway becomes complex | Q29555851 | ||
| Prognostic value of humbug gene overexpression in stage II colon cancer | Q33259349 | ||
| Ethanol inhibition of aspartyl-asparaginyl-beta-hydroxylase in fetal alcohol spectrum disorder: potential link to the impairments in central nervous system neuronal migration | Q33944605 | ||
| cDNA cloning and expression of bovine aspartyl (asparaginyl) beta-hydroxylase | Q34249628 | ||
| An analysis of 412 cases of hepatocellular carcinoma at a Western center | Q34503813 | ||
| EGF-like domains in extracellular matrix proteins: localized signals for growth and differentiation? | Q34504931 | ||
| The significance of Notch1 compared with Notch3 in high metastasis and poor overall survival in hepatocellular carcinoma | Q34612059 | ||
| Notch signaling, gamma-secretase inhibitors, and cancer therapy | Q34653560 | ||
| Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma | Q35894880 | ||
| Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice | Q36421780 | ||
| Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma | Q36455499 | ||
| Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma | Q36881080 | ||
| Upregulation of T-cell factor-4 isoform-responsive target genes in hepatocellular carcinoma | Q36997259 | ||
| siRNA inhibition of aspartyl-asparaginyl β-hydroxylase expression impairs cell motility, Notch signaling, and fetal growth | Q37023897 | ||
| Generation and regeneration of cells of the liver and pancreas | Q37341344 | ||
| The role of signaling pathways in the development and treatment of hepatocellular carcinoma | Q37773788 | ||
| Deregulation of signalling pathways in prognostic subtypes of hepatocellular carcinoma: novel insights from interspecies comparison | Q38080061 | ||
| The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma. | Q39774631 | ||
| Overexpression of aspartyl-(asparaginyl)-beta-hydroxylase in hepatocellular carcinoma is associated with worse surgical outcome | Q43005656 | ||
| Notch signaling in hepatocellular carcinoma: guilty in association! | Q43239248 | ||
| Constitutive Notch2 signaling induces hepatic tumors in mice | Q44601154 | ||
| A critical role for notch signaling in the formation of cholangiocellular carcinomas. | Q50945875 | ||
| Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. | Q54590341 | ||
| Bovine liver aspartyl beta-hydroxylase. Purification and characterization | Q67920946 | ||
| Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma | Q74428408 | ||
| WNT/β-catenin signaling and hepatocellular carcinoma | Q87469831 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| hepatocellular carcinoma | Q1148337 | ||
| P304 | page(s) | 1302-1313 | |
| P577 | publication date | 2014-08-25 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma | |
| P478 | volume | 60 |
| Q36386273 | Activation of signal transduction pathways during hepatic oncogenesis |
| Q35949450 | Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression. |
| Q91622958 | Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma |
| Q98564461 | Aspartate β-hydroxylase as a target for cancer therapy |
| Q36723189 | Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma |
| Q92332826 | Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway |
| Q37485171 | Aspartate-β-hydroxylase (ASPH): A potential therapeutic target in human malignant gliomas |
| Q35091441 | Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma |
| Q95840325 | Aspartate/asparagine-β-hydroxylase: a high-throughput mass spectrometric assay for discovery of small molecule inhibitors |
| Q59354375 | Construction and Characterization of Adenovirus Vectors Encoding Aspartate--Hydroxylase to Preliminary Application in Immunotherapy of Hepatocellular Carcinoma |
| Q47331366 | Ethanol-Induced White Matter Atrophy Is Associated with Impaired Expression of Aspartyl-Asparaginyl-β-Hydroxylase (ASPH) and Notch Signaling in an Experimental Rat Model |
| Q35767923 | High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma |
| Q55378664 | Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition Pathway. |
| Q89926103 | Kinetic parameters of human aspartate/asparagine-β-hydroxylase suggest that it has a possible function in oxygen sensing |
| Q42366399 | Lambda phage-based vaccine induces antitumor immunity in hepatocellular carcinoma |
| Q54111731 | MiR-200a inhibits cell proliferation and EMT by down-regulating the ASPH expression levels and affecting ERK and PI3K/Akt pathways in human hepatoma cells. |
| Q36495723 | Optimized Expression and Purification of Humbug in Pichia pastoris and Its Monoclonal Antibody Preparation |
| Q90127696 | Prometastatic Secretome Trafficking via Exosomes Initiates Pancreatic Cancer Pulmonary Metastasis |
| Q34599527 | Proteomic profile and in silico analysis in metastatic melanoma with and without BRAF mutation |
| Q37679979 | Role of Notch signaling pathway in pancreatic cancer |
| Q39192384 | Role of the Notch signaling in cholangiocarcinoma. |
| Q93207896 | Synthesis of Novel Pyridine-carboxylates as Small-Molecule Inhibitors of Human Aspartate/Asparagine-β-Hydroxylase |
| Q28817788 | The Eighth Central European Conference "Chemistry towards Biology": Snapshot |
| Q47215879 | The Forty-Sixth Euro Congress on Drug Synthesis and Analysis: Snapshot †. |
| Q36853891 | Upregulation of colonic and hepatic tumor overexpressed gene is significantly associated with the unfavorable prognosis marker of human hepatocellular carcinoma |
Search more.